MimiVax's cancer vaccine for glioblastoma narrowly misses Phase 2b goal
A brain cancer effort more than a decade in the making has culminated in a disappointing study result — but researchers behind it are contending there’s enough of a promising signal to give certain patients with ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.